The protein complex that assembles integral membrane β-barrel proteins in the outer membranes of Gram-negative bacteria is an attractive target in the development of new antibiotics. This complex, the β-barrel assembly machine (Bam), contains two essential proteins, BamA and BamD. We have identified a peptide that inhibits the assembly of β-barrel proteins in vitro by characterizing the interaction of BamD with an unfolded substrate protein. This peptide is a fragment of the substrate protein and contains a conserved amino acid sequence. We have demonstrated that mutations of this sequence in the full-length substrate protein impair the protein's assembly, implying that BamD's interaction with this sequence is an important part of the assembly mechanism. Finally, we have found that in vivo expression of a peptide containing this sequence causes growth defects and sensitizes E. coli to antibiotics to which they are normally resistant. Therefore, inhibiting the binding of substrates to BamD is a viable strategy for developing new antibiotics directed against Gram-negative bacteria.
Introduction
Membrane proteins with β-barrel structure are found in the outer membranes of Gramnegative bacteria and in the mitochondria and chloroplasts of eukaryotes. These proteins are assembled into their native membranes by conserved protein complexes, which contain a β-barrel protein of the Omp85 family and some number of accessory proteins (1) (2) (3) (4) (5) (6) . β-barrel assembly is an essential process and, as such, is an attractive target for the development of new antibiotics that could kill Gram-negative pathogens. However, the mechanism by which β-barrel assembly proceeds is only beginning to be elucidated. Structures of the components of the bacterial β-barrel assembly machine (BamA-E) have been determined recently, and several hypotheses about how they facilitate the assembly of its substrates have been proposed (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) .
The β-barrel component, BamA, contains a kinked β-strand, which might allow substrate proteins to be inserted by passing laterally from the lumen of the BamA β-barrel into the hydrophobic membrane (18) . BamA also contains a large soluble domain in addition to its integral β-barrel; this region extends into the periplasmic space between the inner and outer membranes and consists of five polypeptide transport-associated (POTRA) domains (19) . The POTRA domains bind the other four components of the assembly complex, BamB-E, which are lipoproteins. Structural and biochemical studies have suggested that the POTRA domains, BamB, and BamD may interact with substrate proteins during their assembly (13, 15, (19) (20) (21) (22) .
However, more detailed information is required about the nature of those interactions and whether they are critical in the assembly process in order to develop an integrated mechanistic model.
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Only two components of the Bam complex, BamA and BamD, are essential for E. coli viability (2, 23) . BamD is found in all proteobacteria (24, 25) , but it bears no obvious homology to any of the accessory components of the mitochondrial or chloroplastic complexes. It is therefore unclear what its essential function is and whether that function is specific to bacteria. Do the β-barrel assembly complexes in all species use the same mechanism (perhaps with different accessory proteins) or have they evolved different essential components to meet their organism-specific requirements? We have previously demonstrated that BamD binds to two unfolded OMP substrates, OmpA and BamA, and that it directly facilitates the assembly of BamA (21) . In this study, we have characterized this interaction to understand its role in the assembly process carried out by the complete Bam complex and to assess whether interfering with the binding of substrates to BamD might be a viable strategy for developing new antibiotics.
Results

A Peptide Derived from BamA Inhibits OMP Assembly In Vitro
As a first step towards developing an inhibitor of the Bam complex, we assessed whether BamD interacts with substrates in a sequence specific manner and whether that interaction is important in the folding mechanism. We previously demonstrated that unfolded BamA binds to and can be co-purified with soluble BamD-His (i.e. a BamD construct lacking its N-terminal lipid acylation site) in vitro (21) . We performed similar co-purification experiments with unfolded fragments of BamA to determine which region of the BamA sequence BamD recognizes. The BamA protein was divided into two pieces consisting of its soluble POTRA domains and its membrane β-barrel domain ( Figure 1A ); these were separately expressed, purified, and urea-denatured. Their ability to co-purify with soluble BamD-His was then 5 determined. BamD bound the β-barrel domain of the unfolded BamA substrate, but not the isolated POTRA domains ( Figure 1B) . We then further divided the β-barrel of BamA into four pieces and found that BamD specifically bound the C-terminal 96 amino acids of the β-barrel ( Figure 1C ).
We then determined whether this interaction between the BamA C-terminal fragment and BamD is important in the assembly mechanism. We used our previously described in vitro assembly reactions in which unfolded BamA is assembled by the Bam complex in proteoliposomes (21, 26, 27) . In these assays, folding of the substrate protein, BamA, is detected by production of a band of lower apparent molecular weight on a semi-native SDS-PAGE gel; folded β-barrels do not denature under the conditions of these gel assays and consequently migrate faster than their unfolded forms. The C-terminal BamA fragment inhibited the folding of full-length BamA by the BamABCDE complex in a dose-dependent manner, whereas the Nterminal β-barrel fragment was a less effective inhibitor ( Figure 1D ). The folding inhibition thus mirrored the affinity of BamD for the BamA peptides, suggesting that the C-terminal fragment interferes with the assembly of the full-length substrate by competing for binding to BamD. This interaction is therefore part of the assembly mechanism performed by the complete complex.
Because sequences near or at the C-termini of β-barrels have been previously proposed to act as recognition sequences (28) (29) (30) , we examined the ability of five smaller peptides derived from the C-terminal region of BamA to inhibit assembly in our in vitro assay. These peptides consist of overlapping sequences of 15 or 16 residues between amino acids 755 and 810 of BamA ( Figure 2A ). These five peptides were incubated with the Bam proteoliposomes, and fulllength BamA substrate was then added. Only peptide 2, containing residues 765-779 of BamA, 
The Inhibitory Peptide Exploits a Conserved Binding Mechanism
Peptide 2 contains a sequence that was previously identified as a "β-signal" in mitochondrial OMPs. Specifically, the essential peripheral membrane component of the mitochondrial β-barrel assembly machine, Sam35, was shown to bind this sequence in a substrate protein (30) . The identified sequence contains a polar residue followed by a conserved glycine and two hydrophobic residues with intervening non-conserved residues (i.e., a sequence of the form: ζxGxxΦxΦ) (30) . The residues in this putative "β-signal" are conserved in BamA orthologs, including those in clinically important bacteria ( Figure 3A) , and similar sequences can be found in other E. coli OMPs ( Figure S1A ). We demonstrated that this sequence is necessary for binding to BamD; we deleted residues 769-776 from the C-terminal 96-mer and observed that the fragment no longer bound to soluble BamD ( Figure 3B ). Therefore, the inhibitory effect of peptide 2 can be attributed to the eight residues at positions 769-776. We also tested whether similar "β-signal" sequences in another OMP, OmpF, can inhibit BamA assembly in vitro ( Figure S1B ). A C-terminal fragment derived from OmpF is a less potent inhibitor of BamA assembly, but as predicted, deleting its proposed β-signal sequences reduces its inhibitory ability.
This experiment further suggests that the inhibition we observe is not due to a disruption of the Bam complex but rather a competition with substrate, as a fragment of OmpF would not compete with the interactions between the Bam complex components.
Although the putative "β-signal" is conserved, it is relatively non-specific in that only the glycine is invariant; several amino acids of a particular class can appear in the other semiconserved positions. We made point mutations in this sequence in BamA to determine their effect on binding to BamD and on assembly of the full-length protein. In accord with the results obtained in mitochondria, we observed that most of the residues can be mutated without significantly affecting binding (30) . The one exception was the final hydrophobic residue, W776; mutations of this residue to alanine or glutamine reduced its affinity for BamD ( Figure   3C ), and BamA substrates containing these mutations were less efficiently assembled by the wild-type complex both in vitro and in vivo ( Figure 3D ). (The effect of the W776A mutation is more modest than that of the W776Q mutation.) A G771A mutation did not affect binding to BamD, but precluded formation of a stable β-barrel even in detergent solution. Again, this is consistent with the results in mitochondria and indicates that although the glycine is required in the sequence, BamD does not specifically recognize it (30) . Rather the glycine likely plays a structural role and is required to produce a stable, folded β-barrel. In fact, crystal structures of 8 the BamA β-barrel indicate that G771 is adjacent to residues F738 and D740, which interact with the highly conserved residue R661 in loop 6 (8, 9) . These interactions between loop 6 and residues on the inside of the barrel may be important in stabilizing the barrel structure, and we hypothesize that larger amino acids at position 771 may disrupt these interactions.
It is worth noting that some mutations that do not significantly reduce binding to BamD are assembled less efficiently than wild-type BamA (for example, compare S769A in Figures 3C and 3D). Furthermore, the W776A and W776Q BamA substrates only demonstrated defects in binding to BamD in vitro when they were evaluated in the context of the 96-residue fragments; no significant changes in binding affinity were observed when the full-length BamA proteins were used in the co-purifications ( Figure S2 ). Defects in the assembly of these full-length mutant substrates were nevertheless observed ( Figure 3D ). Therefore, the assembly of BamA is more sensitive to changes in the sequence at residues 769-776 than the affinity purifications reveal; BamD may be able to bind to other regions of unfolded BamA when there are mutations in the 769-776 sequence, but assembly is most efficient when binding to this sequence is optimal.
The Inhibitory Peptide Interacts with BamD and is Toxic In Vivo
We expressed peptides derived from BamA in the E. coli periplasm to determine whether one containing the sequence at residues 769-776 interferes with OMP assembly in vivo.
Peptides consisting of approximately 96 amino acids from the N-terminus of BamA (residues 24-119), from the N-terminus of the BamA β-barrel (422-518), and from the C-terminus of BamA (715-810) were fused to the BamA signal sequence followed by a FLAG tag ( Figure 4A ). The 24-119 and 422-518 peptides were used as controls to account, respectively, for the toxic effects of secretion of peptides of this length and of any non-specific unfolded protein stress caused by β-peptides. Under conditions of low-level (uninduced) expression, cells expressing peptides derived from the BamA β-barrel exhibited growth defects on plates and demonstrated increased sensitivity to antibiotics that cannot normally penetrate the OM ( Figure 4B ). Peptides with β-sheet structure might aggregate easily and induce periplasmic stress, which could explain the phenotypes of these strains without invoking any direct effect on the Bam complex (31).
However, the C-terminal 715-810 peptide produces a more severe growth defect (i.e., a smaller colony size and fewer colony-forming units) than the 422-518 peptide, and deleting residues 769-776 reverses this increased toxicity. Deleting residues 769-776 also significantly reduces the sensitivity of the cells to vancomycin and rifampicin, suggesting that the OM barrier is not compromised as severely by expression of that peptide ( Figure 4B , bottom two panels). The deletion of residues 769-776 in the 715-810 peptide serves as a control, which indicates that the toxicity of the 715-810 peptide cannot be attributed solely to non-specific periplasmic stress.
(The 422-518 peptide is included for comparison, but the 769-776 deletion demonstrates the importance of the β-signal sequence.) We therefore conclude that the SAGIALQW sequence, which inhibits BamA assembly in vitro, is also toxic in vivo.
Expression of any of the fragments derived from the BamA β-barrel (422-518, 715-810, and 715-810Δ769-776) results in increased expression of the periplasmic protease, DegP, suggesting that these fragments induce the periplasmic stress response ( Figure S3 ). The stress response changes the transcription of many OMPs, complicating the interpretation of any effects of the expressed fragments on OMP levels in vivo (32) . We observe that the 715-810 fragment reduces the cellular level of LptD slightly more than the other fragments ( Figure S3 ). LptD is the essential, β-barrel component of the machine that transports lipopolysaccharide to the outer leaflet of the OM. The effects on LptD assembly may thus account-at least in part-for the increased toxicity of the 715-810 fragment given that this protein is essential and directly involved in establishing the impermeability of the OM. The expression of the BamA fragments has no obvious effect on the cellular level of full-length BamA, but BamA is also upregulated by the envelope stress response (σ E ) and any inhibition of BamA assembly might be ameliorated in vivo by these transcriptional changes and by the presence of periplasmic chaperones and proteases.
We performed photocrosslinking experiments to establish that the 715-810 peptide interacts with BamD in vivo. p-Benzoylphenylalanine was introduced at several positions in or near the "β-signal" sequence in the 715-810 peptide by unnatural amino acid incorporation (33) (34) (35) . These mutated peptides were expressed at a low (uninduced) level as in the phenotypic experiments described above, and the cells were irradiated with UV light to induce crosslinking to any proteins that interact with the mutated residues. The peptide containing the photocrosslinker at position 776 produced an adduct that reacts with both FLAG and BamD antibodies ( Figure 4D ). This adduct has a molecular weight of ~35 kDa, which is approximately equal to the sum of the molecular weights of the peptide and BamD. Notably, residue W776 is the one amino acid that also appeared to be important for binding to BamD in vitro ( Figure 3C ).
We have thus demonstrated that a peptide containing a conserved sequence in BamA interacts with BamD in vivo and produces growth, OM permeability, and OMP biogenesis defects.
Discussion
The five components of the Bam complex catalyze the assembly of outer membrane proteins with β-barrel structure; deletions or depletions of any of the components result in less 11 efficient OMP assembly in vivo (2, 23, 36 certain OMPs can be assembled in its absence. Rather we suggest that BamD's essentiality in substrate binding reflects a kinetic effect on the overall efficiency of OMP assembly, a specific effect on the assembly of one or a few OMP substrates that are critical for cell growth and OM integrity, or possibly a combination of both kinetic and substrate-specific effects.
We have shown that BamD binds a sequence in unfolded BamA that is the same as the sequence Sam35 binds in mitochondrial OMPs. This implies that aspects of the mechanism of β-barrel assembly are conserved despite the apparent non-conservation of the proteins that carry out those aspects. Sam35 and BamD share no obvious sequence homology but perform the same receptor-like function in binding unfolded substrates at the surface of the membrane into which the substrates are inserted (21, 30) ; therefore, the conservation of the β-barrel assembly mechanism extends beyond the steps performed by BamA. Previous reports demonstrating that some mitochondrial β-barrels can be assembled in bacteria and that some bacterial OMPs can be assembled in mitochondria implied that the assembly complexes have similar substrate recognition mechanisms (40) (41) (42) (43) , and structural studies (13) (14) (15) (44) (45) (46) suggested that BamD might recognize OMP substrates based on its homology to proteins that bind C-terminal peptides (e.g., a component of the mitochondrial translocase, Tom70, a peroxisomal protein receptor, PEX5, and a factor responsible for organizing Hsp chaperone proteins, Hop). Our results connect these observations and provide the underlying molecular basis for substrate recognition, which explains the reciprocity of β-barrel assembly between mitochondria and bacteria.
The recognition sequence, or "β-signal," is found in BamA approximately 30 amino acids removed from the C-terminus and is found in mitochondrial OMPs near, but often not at the Cterminus (30) . However, in other bacterial OMPs, this sequence does sometimes appear at the extreme C-terminus ( Figure S1A ). The C-terminal residues of some bacterial OMPs have been shown to be important for their assembly (28); this observation is consistent with our results that show that the final residue of the "β-signal" is particularly important for binding to BamD (Figures 3 and 4) . Therefore, the positioning of the "β-signal" within OMP sequences may be somewhat variable, and some OMPs may have more than one such sequence (e.g., OmpF).
Perhaps the different positions of the "β-signal" reflect differences in the assembly requirements of different OMPs. 
Materials and Methods
Additional information regarding experimental procedures is provided in the Supporting
Information. Tris, pH 6.8, 4% SDS, 30% glycerol, 0.005% bromophenol blue, 5% β-mercaptoethanol). The proteins in the "input" and these "eluate" samples were separated by SDS-PAGE and stained with Coomassie Blue.
Unfolded Substrate Affinity Purifications
In Vitro Folding Assays
The method for monitoring the in vitro assembly of the β-barrels by the Bam complex has been described previously (21, 26, 27) . The particular adaptations of this method for the experiments described in this paper are explained here. respectively. The final concentrations of the reaction components were: 0.5 µM FLAG-BamA substrate, 100 µM peptide, and ~2.5 µM Bam complex. Each reaction contained ~10% residual DMSO from the peptide stock solutions. All reaction products were analyzed by SDS-PAGE and immunoblotting as described above.
BamA Folding Inhibition in Bam Proteoliposomes
OmpA Folding Inhibition in Bam Proteoliposomes
The peptides containing 15 or 16 amino acids were dissolved at 1 mg/mL in 1:1 TBS (pH DMSO from the peptide stock solutions. All reaction products were analyzed by SDS-PAGE and immunoblotting as described above.
Folding of Mutated FLAG-BamA Substrates in Detergent and Proteoliposomes
All FLAG-tagged substrate proteins were prepared at a concentration of 5 µM in 8 M urea and then diluted ten-fold into a TBS (pH 8) solution containing 0.5% LDAO, empty liposomes, or Bam complex proteoliposomes as described above (with the exception that no inhibitory peptides were included). The folding reactions were incubated at 25 o C for 60 min and then stopped with ice-cold 2x SDS sample loading buffer. The quenched samples were run on semi-native SDS-PAGE and immunoblotted as described above.
In Vivo Assembly of FLAG-BamA Substrates BL21(DE3) cells harboring pJW152, pJW153, pJW154, pJW155, pJW156, pJW157 or pJW158 were grown at 37 o C in LB supplemented with 50 µg/mL carbenicillin and 0.2% glucose to an OD 600 of approximately 0.3. The cells from a 1 mL sample were collected by centrifugation at 20,000 x g for 5 min and then flash frozen. Once all samples were collected and frozen, they were thawed to room temperature and resuspended in 20 mM Tris (pH 8), 1 mM EDTA, 5 mg/mL lysozyme. The suspensions were subjected to two freeze/thaw cycles by freezing in a CO 2 /acetone bath and warming to room temperature in water. The thawed samples were then treated with lysis solution (20 mM Tris (pH 8), 10 mM EDTA, 4% SDS). The samples were vortexed for 10 seconds and subsequently rocked at room temperature for 30 min.
The resulting cell extracts were mixed 1:1 with TBS (pH 8). SDS sample loading buffer was added and the samples were subjected to SDS-PAGE (4-20% gel) at 150 V for 90 min at 4 o C.
The proteins were transferred from the gel to a PVDF membrane via a Pierce G2 fast blotter in 1-step transfer buffer at 25 V for 15 minutes. The folded and unfolded forms of the FLAG-tagged BamA proteins were detected by immunoblotting with anti-FLAG-HRP antibodies. Fragments contained residues 1-23 of BamA (i.e., the signal sequence plus three additional 27 residues), followed by a FLAG-tag, and finally the sequences designated in the purple boxes 
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